IDEAS home Printed from https://ideas.repec.org/e/pbo86.html
   My authors  Follow this author

Joan-Ramon Borrell

Personal Details

First Name:Joan-Ramon
Middle Name:
Last Name:Borrell
Suffix:
RePEc Short-ID:pbo86
http://www.ub.edu/gim/membre/joan-ramon-borrell/
Secció de Polítiques Públiques Departament d'Econometria, Estadística i Economia Aplicada Facultat d'Economia i Empresa Universitat de Barcelona C/ John M. Keynes 1-11 08034 Barcelona Spain
(34)934039722
Terminal Degree:1999 Facultat d'Economia i Empresa; Universitat de Barcelona (from RePEc Genealogy)

Affiliation

(33%) Grup de Recerca en Governs i Mercats (GiM)
Institut de Recerca en Economia Aplicada (IREA)
Facultat d'Economia i Empresa
Universitat de Barcelona

Barcelona, Spain
http://www.ub.edu/gim/

: +34 93 402 1945
+34 93 402 4573
Carrer Tinent-Coronel Valenzuela 1-11, 08034 Barcelona
RePEc:edi:gprubes (more details at EDIRC)

(33%) Institut de Recerca en Economia Aplicada (IREA)
Facultat d'Economia i Empresa
Universitat de Barcelona

Barcelona, Spain
http://www.ub.edu/irea/

: Phone: 00934037241
00934037242
c/ Tinent Coronel Valenzuela, 1-11, 08034 Barcelona
RePEc:edi:irubaes (more details at EDIRC)

(32%) Facultat d'Economia i Empresa
Universitat de Barcelona

Barcelona, Spain
http://www.ub.es/economiaempresa/

: +34 93 402 43 13cazza

Diagonal 690-696, 08034 Barcelona
RePEc:edi:feubaes (more details at EDIRC)

(1%) Centro Sector Público - Sector Privado (SP-SP)
IESE Business School
Universidad de Navarra

Barcelona, Spain
http://www.iese.edu/ppsrc

: + 34 93 253 43 33
+ 34 93 253 43 43
Av. Pearson, 21 08034 Barcelona
RePEc:edi:spsiees (more details at EDIRC)

(1%) Centre de Recerca en Economia i Salut (CRES)
Universitat Pompeu Fabra

Barcelona, Spain
http://www.upf.edu/cres/

: ( 3) 542 26 09
( 3) 542 23 62
P/ Circumval.lació, 8., 08003 Barcelona
RePEc:edi:esupfes (more details at EDIRC)

Research output

as
Jump to: Working papers Articles Chapters

Working papers

  1. Valeria Bernardo & Joan-Ramon Borrell & Jordi Perdiguero, 2015. "“Fast Charging Stations: Simulating Entry and Location in a Game of Strategic Interaction”," IREA Working Papers 201513, University of Barcelona, Research Institute of Applied Economics, revised May 2015.
  2. Joan Ramón Borrell & Juan Luís Jiménez & Carmen García, 2012. "Evaluating antitrust leniency programs," Working Papers XREAP2012-01, Xarxa de Referència en Economia Aplicada (XREAP), revised Jan 2012.
  3. Jordi Perdiguero & Joan-Ramon Borrell, 2012. "Driving competition in local gasoline markets," Working Papers XREAP2012-04, Xarxa de Referència en Economia Aplicada (XREAP), revised Mar 2012.
  4. Joan-Ramon Borrell & Laura Fernández-Villadangos, 2010. "Clustering or scattering: the underlying reason for regulating distance among retail outlets," Working Papers XREAP2010-12, Xarxa de Referència en Economia Aplicada (XREAP), revised Dec 2010.
  5. Joan-Ramon Borrell & Laura Fernández-Villadangos, 2009. "Assessing excess profits from different entry regulations," Working Papers XREAP2009-03, Xarxa de Referència en Economia Aplicada (XREAP), revised Apr 2009.
  6. Iván Moreno Torres & Jaume Puig & Joan-Ramon Borrell-Arqué, 2007. "Generic entry into a regulated pharmaceutical market," Economics Working Papers 1014, Department of Economics and Business, Universitat Pompeu Fabra.
  7. Joan-Ramon Borrell & Mara Tolosa, 2005. "Endogenous Antitrust: Cross-Country Evidence on the Impact of Competition-Enhancing Policies on Productivity," Industrial Organization 0504010, University Library of Munich, Germany.
  8. Joan Ramon Borrell Arque, 2004. "Las patentes aceleran o retrasan la comercializacion de nuevos medicamentos en los paises en desarrollo?," Working Papers in Economics 122, Universitat de Barcelona. Espai de Recerca en Economia.
  9. Joan-Ramon Borrell & Jayashree Watal, 2002. "Impact of Patents on Access to HIV/AIDS Drugs in Developing Countries," CID Working Papers 92, Center for International Development at Harvard University.
  10. Joan Ramon Borrell Arque, 2001. "Drug price differentials caused by de-listing and price cap policies," Working Papers in Economics 70, Universitat de Barcelona. Espai de Recerca en Economia.
  11. Joan Ramon Borrell Arque, 1997. "Prices of Medicines a Case-Study on the impact of the rate-of-return regulation in the United Kingdom," Working Papers in Economics 21, Universitat de Barcelona. Espai de Recerca en Economia.

Articles

  1. José Manuel Ordóñez†De†Haro & Joan†Ramon Borrell & Juan Luis Jiménez, 2018. "The European Commission's Fight against Cartels (1962–2014): A Retrospective and Forensic Analysis," Journal of Common Market Studies, Wiley Blackwell, vol. 56(5), pages 1087-1107, July.
  2. Bernardo, Valeria & Borrell, Joan-Ramon & Perdiguero, Jordi, 2016. "Fast charging stations: Simulating entry and location in a game of strategic interaction," Energy Economics, Elsevier, vol. 60(C), pages 293-305.
  3. Joan-Ramon Borrell & Juan Luis Jiménez & Carmen García, 2014. "Evaluating Antitrust Leniency Programs," Journal of Competition Law and Economics, Oxford University Press, vol. 10(1), pages 107-136.
  4. Iván Moreno-Torres & Jaume Puig-Junoy & Joan-Ramon Borrell, 2009. "Generic Entry into the Regulated Spanish Pharmaceutical Market," Review of Industrial Organization, Springer;The Industrial Organization Society, vol. 34(4), pages 373-388, June.
  5. Joan Ramon Borrell & Juan Luis Jiménez, 2008. "The drivers of antitrust effectiveness," Hacienda Pública Española, IEF, vol. 185(2), pages 69-88, July.
  6. Joan-Ramon Borrell & Mara Tolosa, 2008. "Endogenous antitrust: cross-country evidence on the impact of competition-enhancing policies on productivity," Applied Economics Letters, Taylor & Francis Journals, vol. 15(11), pages 827-831.
  7. Joan-Ramon Borrell, 2007. "Pricing and patents of HIV/AIDS drugs in developing countries," Applied Economics, Taylor & Francis Journals, vol. 39(4), pages 505-518.
  8. Joan-Ramon Borrell, 2005. "Patents and the faster introduction of new drugs in developing countries," Applied Economics Letters, Taylor & Francis Journals, vol. 12(6), pages 379-382.
  9. Joan-Ramon Borrell, 2003. "Drug Price Differentials Caused by Formularies and Price Caps," International Journal of the Economics of Business, Taylor & Francis Journals, vol. 10(1), pages 35-48.
  10. Rosa Nonell & Joan-Ramon Borrell, 2001. "Public Demand for Medicines, Price Regulation, and Government — Industry Relationships in Spain," Environment and Planning C, , vol. 19(1), pages 119-134, February.
  11. Rosa Nonell & Joan-Ramon Borrell, 2001. "Public demand for medicines, price regulation, and government - industry relationships in Spain," Environment and Planning C: Government and Policy, Pion Ltd, London, vol. 19(1), pages 119-134, February.

Chapters

  1. J.R. Borrell Arqué & A. Costas Comesa-a & R. Nonell Torres, 2005. "Regulation and competition in pharmaceutical markets," Chapters,in: The Public Financing of Pharmaceuticals, chapter 4 Edward Elgar Publishing.

Citations

Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.

Blog mentions

As found by EconAcademics.org, the blog aggregator for Economics research:
  1. Joan-Ramon Borrell & Laura Fernández-Villadangos, 2009. "Assessing excess profits from different entry regulations," Working Papers XREAP2009-03, Xarxa de Referència en Economia Aplicada (XREAP), revised Apr 2009.

    Mentioned in:

    1. Un ejemplo clásico de restricciones a la entrada: el caso de las farmacias
      by Gerard Llobet in Nada Es Gratis on 2013-05-07 11:00:29

Working papers

  1. Valeria Bernardo & Joan-Ramon Borrell & Jordi Perdiguero, 2015. "“Fast Charging Stations: Simulating Entry and Location in a Game of Strategic Interaction”," IREA Working Papers 201513, University of Barcelona, Research Institute of Applied Economics, revised May 2015.

    Cited by:

    1. Motoaki, Yutaka & Yi, Wenqi & Salisbury, Shawn, 2018. "Empirical analysis of electric vehicle fast charging under cold temperatures," Energy Policy, Elsevier, vol. 122(C), pages 162-168.
    2. Yang, Woosuk, 2018. "A user-choice model for locating congested fast charging stations," Transportation Research Part E: Logistics and Transportation Review, Elsevier, vol. 110(C), pages 189-213.
    3. Motoaki, Yutaka & Shirk, Matthew G., 2017. "Consumer behavioral adaption in EV fast charging through pricing," Energy Policy, Elsevier, vol. 108(C), pages 178-183.
    4. Han Wu & Dongxiao Niu, 2017. "Study on Influence Factors of Electric Vehicles Charging Station Location Based on ISM and FMICMAC," Sustainability, MDPI, Open Access Journal, vol. 9(4), pages 1-19, March.

  2. Joan Ramón Borrell & Juan Luís Jiménez & Carmen García, 2012. "Evaluating antitrust leniency programs," Working Papers XREAP2012-01, Xarxa de Referència en Economia Aplicada (XREAP), revised Jan 2012.

    Cited by:

    1. Dennis Sánchez Navarro, 2013. "Eficacia y asimetrías de los programas de delación en un contexto multimercado: un análisis del caso colombiano en el marco del TLC con Estados Unidos," Estudios Económicos SIC 010905, Superintendencia de Industria y Comercio.
    2. Dong, Ailin & Massa, Massimo & Zaldokas, Alminas, 2016. "Busted! Now What? Effects of Cartel Enforcement on Firm Value and Corporate Policies," CEPR Discussion Papers 11470, C.E.P.R. Discussion Papers.
    3. Chen, Zhiqi & Ghosh, Subhadip & Ross, Thomas W., 2015. "Denying leniency to cartel instigators: Costs and benefits," International Journal of Industrial Organization, Elsevier, vol. 41(C), pages 19-29.
    4. Catalina Bolancé & Zuhair Bahraoui & Ramon Alemany, 2015. "Estimating extreme value cumulative distribution functions using bias-corrected kernel approaches," Working Papers XREAP2015-01, Xarxa de Referència en Economia Aplicada (XREAP), revised Jan 2015.
    5. Anna Castañer & Mª Mercè Claramunt, 2014. "Optimal stop-loss reinsurance: a dependence analysis," Working Papers XREAP2014-04, Xarxa de Referència en Economia Aplicada (XREAP), revised Apr 2014.
    6. Esther Vayá & José Ramón García & Joaquim Murillo & Javier Romaní & Jordi Suriñach, 2016. "“Economic Impact of Cruise Activity: The Port of Barcelona”," AQR Working Papers 201609, University of Barcelona, Regional Quantitative Analysis Group, revised Nov 2016.
    7. Tebbe, Eva, 2018. "Once bitten, twice shy? Market size affects the effectiveness of a leniency program by (de-)activating hysteresis effects," Annual Conference 2017 (Vienna): Alternative Structures for Money and Banking 168304, Verein für Socialpolitik / German Economic Association.
    8. Mercedes Ayuso & Montserrat Guillén & Jens Perch Nielsen, 2016. "Improving automobile insurance ratemaking using telematics: incorporating mileage and driver behaviour data," Working Papers XREAP2016-08, Xarxa de Referència en Economia Aplicada (XREAP), revised Dec 2016.
    9. Andrey V. Makarov, 2014. "Comparative Analusis Of Antitrust Policy Against Collusion In Some Transition Economies: Challenges For Effectiveness," HSE Working papers WP BRP 20/PA/2014, National Research University Higher School of Economics.
    10. Sánchez Navarro, Dennis, 2013. "Eficacia y asimetrías de los programas de delación en un contexto multi-mercado: un análisis del caso colombiano en el marco del TLC con Estados Unidos
      [Efficacy and asymmetries of the leniency pro
      ," MPRA Paper 48699, University Library of Munich, Germany.
    11. Joseph E. Harrington Jr. & Myong-Hun Chang, 2015. "When Can We Expect a Corporate Leniency Program to Result in Fewer Cartels?," Journal of Law and Economics, University of Chicago Press, vol. 58(2), pages 417-449.
    12. Antonio Manresa & Ferran Sancho, 2012. "Leontief versus Ghosh: two faces of the same coin," Working Papers XREAP2012-18, Xarxa de Referència en Economia Aplicada (XREAP), revised Oct 2012.

  3. Jordi Perdiguero & Joan-Ramon Borrell, 2012. "Driving competition in local gasoline markets," Working Papers XREAP2012-04, Xarxa de Referència en Economia Aplicada (XREAP), revised Mar 2012.

    Cited by:

    1. Daniel Albalate & Jordi Perdiguero, 2012. "“Entry Regulation Asymmetries and Gasoline Competition in a Mixed Motorway Network”," IREA Working Papers 201218, University of Barcelona, Research Institute of Applied Economics, revised Nov 2012.
    2. Catalina Bolancé & Zuhair Bahraoui & Ramon Alemany, 2015. "Estimating extreme value cumulative distribution functions using bias-corrected kernel approaches," Working Papers XREAP2015-01, Xarxa de Referència en Economia Aplicada (XREAP), revised Jan 2015.
    3. Anna Castañer & Mª Mercè Claramunt, 2014. "Optimal stop-loss reinsurance: a dependence analysis," Working Papers XREAP2014-04, Xarxa de Referència en Economia Aplicada (XREAP), revised Apr 2014.
    4. Esther Vayá & José Ramón García & Joaquim Murillo & Javier Romaní & Jordi Suriñach, 2016. "“Economic Impact of Cruise Activity: The Port of Barcelona”," AQR Working Papers 201609, University of Barcelona, Regional Quantitative Analysis Group, revised Nov 2016.
    5. Mercedes Ayuso & Montserrat Guillén & Jens Perch Nielsen, 2016. "Improving automobile insurance ratemaking using telematics: incorporating mileage and driver behaviour data," Working Papers XREAP2016-08, Xarxa de Referència en Economia Aplicada (XREAP), revised Dec 2016.
    6. Anna Castañer & Mª Mercè Claramunt & Alba Tadeo & Javier Varea, 2016. "Modelización de la dependencia del número de siniestros. Aplicación a Solvencia II," Working Papers XREAP2016-01, Xarxa de Referència en Economia Aplicada (XREAP), revised Sep 2016.
    7. Antonio Manresa & Ferran Sancho, 2012. "Leontief versus Ghosh: two faces of the same coin," Working Papers XREAP2012-18, Xarxa de Referència en Economia Aplicada (XREAP), revised Oct 2012.

  4. Joan-Ramon Borrell & Laura Fernández-Villadangos, 2010. "Clustering or scattering: the underlying reason for regulating distance among retail outlets," Working Papers XREAP2010-12, Xarxa de Referència en Economia Aplicada (XREAP), revised Dec 2010.

    Cited by:

    1. Bernardo, Valeria & Borrell, Joan-Ramon & Perdiguero, Jordi, 2016. "Fast charging stations: Simulating entry and location in a game of strategic interaction," Energy Economics, Elsevier, vol. 60(C), pages 293-305.
    2. Vogler, Sabine & Habimana, Katharina & Arts, Danielle, 2014. "Does deregulation in community pharmacy impact accessibility of medicines, quality of pharmacy services and costs? Evidence from nine European countries," Health Policy, Elsevier, vol. 117(3), pages 311-327.
    3. Reigadinha, Tânia & Godinho, Pedro & Dias, Joana, 2017. "Portuguese food retailers – Exploring three classic theories of retail location," Journal of Retailing and Consumer Services, Elsevier, vol. 34(C), pages 102-116.

  5. Joan-Ramon Borrell & Laura Fernández-Villadangos, 2009. "Assessing excess profits from different entry regulations," Working Papers XREAP2009-03, Xarxa de Referència en Economia Aplicada (XREAP), revised Apr 2009.

    Cited by:

    1. Catalina Bolancé & Zuhair Bahraoui & Ramon Alemany, 2015. "Estimating extreme value cumulative distribution functions using bias-corrected kernel approaches," Working Papers XREAP2015-01, Xarxa de Referència en Economia Aplicada (XREAP), revised Jan 2015.
    2. Anna Castañer & Mª Mercè Claramunt, 2014. "Optimal stop-loss reinsurance: a dependence analysis," Working Papers XREAP2014-04, Xarxa de Referència en Economia Aplicada (XREAP), revised Apr 2014.
    3. Esther Vayá & José Ramón García & Joaquim Murillo & Javier Romaní & Jordi Suriñach, 2016. "“Economic Impact of Cruise Activity: The Port of Barcelona”," AQR Working Papers 201609, University of Barcelona, Regional Quantitative Analysis Group, revised Nov 2016.
    4. Mercedes Ayuso & Montserrat Guillén & Jens Perch Nielsen, 2016. "Improving automobile insurance ratemaking using telematics: incorporating mileage and driver behaviour data," Working Papers XREAP2016-08, Xarxa de Referència en Economia Aplicada (XREAP), revised Dec 2016.
    5. Anna Castañer & Mª Mercè Claramunt & Alba Tadeo & Javier Varea, 2016. "Modelización de la dependencia del número de siniestros. Aplicación a Solvencia II," Working Papers XREAP2016-01, Xarxa de Referència en Economia Aplicada (XREAP), revised Sep 2016.
    6. Antonio Manresa & Ferran Sancho, 2012. "Leontief versus Ghosh: two faces of the same coin," Working Papers XREAP2012-18, Xarxa de Referència en Economia Aplicada (XREAP), revised Oct 2012.

  6. Iván Moreno Torres & Jaume Puig & Joan-Ramon Borrell-Arqué, 2007. "Generic entry into a regulated pharmaceutical market," Economics Working Papers 1014, Department of Economics and Business, Universitat Pompeu Fabra.

    Cited by:

    1. Appelt, Silvia, 2010. "Authorized Generic Entry prior to Patent Expiry: Reassessing Incentives for Independent Generic Entry," Discussion Papers in Economics 11476, University of Munich, Department of Economics.
    2. Pamina Koenig & Megan Macgarvie, 2011. "Regulatory policy and the location of bio-pharmaceutical foreign direct investment in Europe," Post-Print halshs-00754522, HAL.
    3. Appelt, Silvia, 2010. "Authorized Generic Entry prior to Patent Expiry: Reassessing Incentives for Independent Generic Entry," Discussion Paper Series of SFB/TR 15 Governance and the Efficiency of Economic Systems 357, Free University of Berlin, Humboldt University of Berlin, University of Bonn, University of Mannheim, University of Munich.
    4. Simanjuntak, Destrina Grace & Tjandrawinata, Raymond R., 2011. "A study on influencers of total sales revenue of generic pharmaceutical companies in Indonesia," MPRA Paper 31628, University Library of Munich, Germany.

  7. Joan-Ramon Borrell & Mara Tolosa, 2005. "Endogenous Antitrust: Cross-Country Evidence on the Impact of Competition-Enhancing Policies on Productivity," Industrial Organization 0504010, University Library of Munich, Germany.

    Cited by:

    1. Joan-Ramon Borrell & Juan Luis Jiménez & Carmen García, 2014. "Evaluating Antitrust Leniency Programs," Journal of Competition Law and Economics, Oxford University Press, vol. 10(1), pages 107-136.
    2. Ma, Tay-Cheng, 2010. "Competition authority independence, antitrust effectiveness, and institutions," International Review of Law and Economics, Elsevier, vol. 30(3), pages 226-235, September.
    3. Tay-Cheng Ma, 2012. "Legal tradition and antitrust effectiveness," Empirical Economics, Springer, vol. 43(3), pages 1263-1297, December.

  8. Joan-Ramon Borrell & Jayashree Watal, 2002. "Impact of Patents on Access to HIV/AIDS Drugs in Developing Countries," CID Working Papers 92, Center for International Development at Harvard University.

    Cited by:

    1. Joan-Ramon Borrell, 2007. "Pricing and patents of HIV/AIDS drugs in developing countries," Applied Economics, Taylor & Francis Journals, vol. 39(4), pages 505-518.
    2. Joan Ramon Borrell Arque, 2004. "Las patentes aceleran o retrasan la comercializacion de nuevos medicamentos en los paises en desarrollo?," Working Papers in Economics 122, Universitat de Barcelona. Espai de Recerca en Economia.

Articles

  1. Bernardo, Valeria & Borrell, Joan-Ramon & Perdiguero, Jordi, 2016. "Fast charging stations: Simulating entry and location in a game of strategic interaction," Energy Economics, Elsevier, vol. 60(C), pages 293-305.
    See citations under working paper version above.
  2. Joan-Ramon Borrell & Juan Luis Jiménez & Carmen García, 2014. "Evaluating Antitrust Leniency Programs," Journal of Competition Law and Economics, Oxford University Press, vol. 10(1), pages 107-136.
    See citations under working paper version above.
  3. Iván Moreno-Torres & Jaume Puig-Junoy & Joan-Ramon Borrell, 2009. "Generic Entry into the Regulated Spanish Pharmaceutical Market," Review of Industrial Organization, Springer;The Industrial Organization Society, vol. 34(4), pages 373-388, June.

    Cited by:

    1. Herr, Annika & Suppliet, Moritz, 2012. "Pharmaceutical prices under regulation: Tiered co-payments and reference pricing in Germany," DICE Discussion Papers 48, University of Düsseldorf, Düsseldorf Institute for Competition Economics (DICE).
    2. Liu, Ya-Ming & Cheng, Jur-Shan, 2012. "Determinants of generic entry in the regulated Taiwanese prescription drug market," Health Policy, Elsevier, vol. 108(2), pages 228-235.
    3. Brekke, Kurt R. & Canta, Chiara & Straume, Odd Rune, 2015. "Does Reference Pricing Drive Out Generic Competition in Pharmaceutical Markets? Evidence from a Policy Reform," Discussion Paper Series in Economics 11/2015, Norwegian School of Economics, Department of Economics.
    4. Melisa Newham & Jo Seldeslachts & Albert Banal-Estañol, 2018. "Common ownership and market entry: Evidence from the pharmaceutical industry," Economics Working Papers 1612, Department of Economics and Business, Universitat Pompeu Fabra.
    5. Jaume Puig-Junoy, 2012. "Do Higher-Priced Generic Medicines Enjoy a Competitive Advantage Under Reference Pricing?," Applied Health Economics and Health Policy, Springer, vol. 10(6), pages 441-451, November.
    6. Patricia M. Danzon & Michael F. Furukawa, 2011. "Cross-National Evidence on Generic Pharmaceuticals: Pharmacy vs. Physician-Driven Markets," NBER Working Papers 17226, National Bureau of Economic Research, Inc.
    7. Katharina Elisabeth Fischer & Tom Stargardt, 2016. "The diffusion of generics after patent expiry in Germany," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(8), pages 1027-1040, November.
    8. Kurt R. Brekke & Chiara Canta & Odd Rune Straume, 2015. "Reference pricing with endogenous generic entry," NIPE Working Papers 2/2015, NIPE - Universidade do Minho.
    9. Mikael Linden, 2017. "Price variability, generic substitution, market size and multimarket contacts in the Finnish beta blocker market," Economia e Politica Industriale: Journal of Industrial and Business Economics, Springer;Associazione Amici di Economia e Politica Industriale, vol. 44(2), pages 161-174, June.
    10. Birg, Laura, 2019. "Reference pricing and parallel imports: Evidence from Germany," Center for European, Governance and Economic Development Research Discussion Papers 362, University of Goettingen, Department of Economics.
    11. Ivan Moreno-Torres, 2011. "What if there was a stronger pharmaceutical price competition in Spain? When regulation has a similar effect to collusion," Working Papers XREAP2011-02, Xarxa de Referència en Economia Aplicada (XREAP), revised May 2011.
    12. Costa-i-Font, Joan & Varol, Nebibe & McGuire, Alistair, 2011. "Does pharmaceutical price regulation affect the adoption of generic competition?: evidence from the OECD, 1999-2008," LSE Research Online Documents on Economics 37537, London School of Economics and Political Science, LSE Library.
    13. Ivan Moreno-Torres, 2011. "Generic drugs in Spain: price competition vs. moral hazard," Working Papers XREAP2011-04, Xarxa de Referència en Economia Aplicada (XREAP), revised May 2011.

  4. Joan Ramon Borrell & Juan Luis Jiménez, 2008. "The drivers of antitrust effectiveness," Hacienda Pública Española, IEF, vol. 185(2), pages 69-88, July.

    Cited by:

    1. Joan-Ramon Borrell & Juan Luis Jiménez & Carmen García, 2014. "Evaluating Antitrust Leniency Programs," Journal of Competition Law and Economics, Oxford University Press, vol. 10(1), pages 107-136.
    2. Marvao, Catarina, 2014. "Heterogeneous Penalties and Private Information," SITE Working Paper Series 29, Stockholm School of Economics, Stockholm Institute of Transition Economics.
    3. Tebbe, Eva, 2018. "Once bitten, twice shy? Market size affects the effectiveness of a leniency program by (de-)activating hysteresis effects," Annual Conference 2017 (Vienna): Alternative Structures for Money and Banking 168304, Verein für Socialpolitik / German Economic Association.
    4. Juan Jiménez & Jordi Perdiguero, 2012. "Does Rigidity of Prices Hide Collusion?," Review of Industrial Organization, Springer;The Industrial Organization Society, vol. 41(3), pages 223-248, November.
    5. Catarina Marvão, 2016. "The EU Leniency Programme and Recidivism," Review of Industrial Organization, Springer;The Industrial Organization Society, vol. 48(1), pages 1-27, February.
    6. Trujillo, Lourdes & González, María Manuela & Jiménez, Juan Luis, 2013. "An overview on the reform process of African ports," Utilities Policy, Elsevier, vol. 25(C), pages 12-22.
    7. Marvão, Catarina, 2014. "Heterogeneous Penalties and Private Information," Konkurrensverket Working Paper Series in Law and Economics 2014:1, Konkurrensverket (Swedish Competition Authority).
    8. Michael, Bryane, 2017. "The Effect of Competition Law on Brunei’s Small and Medium Enterprises," EconStor Preprints 169114, ZBW - Leibniz Information Centre for Economics.

  5. Joan-Ramon Borrell & Mara Tolosa, 2008. "Endogenous antitrust: cross-country evidence on the impact of competition-enhancing policies on productivity," Applied Economics Letters, Taylor & Francis Journals, vol. 15(11), pages 827-831.
    See citations under working paper version above.
  6. Joan-Ramon Borrell, 2007. "Pricing and patents of HIV/AIDS drugs in developing countries," Applied Economics, Taylor & Francis Journals, vol. 39(4), pages 505-518.

    Cited by:

    1. Patrick Leoni & Alvaro Sandroni, 2016. "Can patent duration hinder medical innovation," International Journal of Health Economics and Management, Springer, vol. 16(4), pages 397-406, December.
    2. José Cuesta, 2008. "Does a Mature AIDS Epidemic Threaten Growth?," Research Department Publications 4567, Inter-American Development Bank, Research Department.
    3. José Cuesta, 2008. "¿Una epidemia de SIDA en su etapa madura es una amenaza para el crecimiento?," Research Department Publications 4568, Inter-American Development Bank, Research Department.

  7. Joan-Ramon Borrell, 2005. "Patents and the faster introduction of new drugs in developing countries," Applied Economics Letters, Taylor & Francis Journals, vol. 12(6), pages 379-382.

    Cited by:

    1. Mark Duggan & Craig Garthwaite & Aparajita Goyal, 2014. "The Market Impacts Of Pharmaceutical Product Patents In Developing Countries: Evidence From India," Discussion Papers 14-005, Stanford Institute for Economic Policy Research.
    2. Margaret Kyle & Yi Qian, 2014. "Intellectual Property Rights and Access to Innovation: Evidence from TRIPS," NBER Working Papers 20799, National Bureau of Economic Research, Inc.

  8. Joan-Ramon Borrell, 2003. "Drug Price Differentials Caused by Formularies and Price Caps," International Journal of the Economics of Business, Taylor & Francis Journals, vol. 10(1), pages 35-48.

    Cited by:

    1. García-Alonso, M. D. C. & Garcia-Marinoso, B., 2007. "The strategic interaction between firms and formulary committees: effects on the prices of new drugs," Working Papers 07/16, Department of Economics, City University London.
    2. Aidan Hollis & Stephen Law, 2004. "A National Formulary for Canada," Canadian Public Policy, University of Toronto Press, vol. 30(4), pages 445-452, December.
    3. García-Alonso, M. D. C. & Mariñoso, B. G., 2005. "The relationship of drug reimbursement with the price and the quality of pharmaceutical innovations," Working Papers 05/02, Department of Economics, City University London.
    4. Iván Moreno-Torres & Jaume Puig-Junoy & Josep Raya, 2011. "The impact of repeated cost containment policies on pharmaceutical expenditure: experience in Spain," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 12(6), pages 563-573, December.
    5. Ivan Moreno-Torres, 2011. "What if there was a stronger pharmaceutical price competition in Spain? When regulation has a similar effect to collusion," Working Papers XREAP2011-02, Xarxa de Referència en Economia Aplicada (XREAP), revised May 2011.
    6. Ivan Moreno-Torres, 2011. "Generic drugs in Spain: price competition vs. moral hazard," Working Papers XREAP2011-04, Xarxa de Referència en Economia Aplicada (XREAP), revised May 2011.
    7. Iván Moreno-Torres & Jaume Puig-Junoy & Joan-Ramon Borrell, 2009. "Generic Entry into the Regulated Spanish Pharmaceutical Market," Review of Industrial Organization, Springer;The Industrial Organization Society, vol. 34(4), pages 373-388, June.

  9. Rosa Nonell & Joan-Ramon Borrell, 2001. "Public Demand for Medicines, Price Regulation, and Government — Industry Relationships in Spain," Environment and Planning C, , vol. 19(1), pages 119-134, February.

    Cited by:

    1. Puig-Junoy, Jaume, 2004. "Incentives and pharmaceutical reimbursement reforms in Spain," Health Policy, Elsevier, vol. 67(2), pages 149-165, February.

  10. Rosa Nonell & Joan-Ramon Borrell, 2001. "Public demand for medicines, price regulation, and government - industry relationships in Spain," Environment and Planning C: Government and Policy, Pion Ltd, London, vol. 19(1), pages 119-134, February.

    Cited by:

    1. Puig-Junoy, Jaume, 2004. "Incentives and pharmaceutical reimbursement reforms in Spain," Health Policy, Elsevier, vol. 67(2), pages 149-165, February.
    2. Jaume Puig, 2003. "Incentives and pharmaceutical reimbursement reforms in Spain," Economics Working Papers 679, Department of Economics and Business, Universitat Pompeu Fabra.
    3. Jaume Puig, 2003. "Incentives and pharmaceutical reimbursement reforms in Spain," Working Papers, Research Center on Health and Economics 679, Department of Economics and Business, Universitat Pompeu Fabra.
    4. Rosa Rodríguez-Monguió & Fernando Villar, 2006. "Healthcare Rationing in Spain," PharmacoEconomics, Springer, vol. 24(6), pages 537-548, June.

Chapters

    Sorry, no citations of chapters recorded.

More information

Research fields, statistics, top rankings, if available.

Statistics

Access and download statistics for all items

Rankings

This author is among the top 5% authors according to these criteria:
  1. Record of graduates

Co-authorship network on CollEc

NEP Fields

NEP is an announcement service for new working papers, with a weekly report in each of many fields. This author has had 7 papers announced in NEP. These are the fields, ordered by number of announcements, along with their dates. If the author is listed in the directory of specialists for this field, a link is also provided.
  1. NEP-REG: Regulation (6) 2001-11-21 2005-04-16 2007-03-10 2007-04-09 2011-01-23 2012-04-10. Author is listed
  2. NEP-COM: Industrial Competition (5) 2005-04-16 2007-03-10 2007-04-09 2012-04-10 2015-05-30. Author is listed
  3. NEP-URE: Urban & Real Estate Economics (3) 2011-01-23 2012-04-10 2015-05-30
  4. NEP-HEA: Health Economics (2) 2001-11-21 2007-04-09
  5. NEP-IND: Industrial Organization (2) 2007-04-09 2012-04-10
  6. NEP-MIC: Microeconomics (2) 2007-03-10 2007-04-09
  7. NEP-CSE: Economics of Strategic Management (1) 2015-05-30
  8. NEP-GEO: Economic Geography (1) 2011-01-23
  9. NEP-GTH: Game Theory (1) 2015-05-30
  10. NEP-IPR: Intellectual Property Rights (1) 2007-04-09
  11. NEP-TID: Technology & Industrial Dynamics (1) 2007-03-10
  12. NEP-TRE: Transport Economics (1) 2015-05-30

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Joan-Ramon Borrell should log into the RePEc Author Service.

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.

IDEAS is a RePEc service hosted by the Research Division of the Federal Reserve Bank of St. Louis . RePEc uses bibliographic data supplied by the respective publishers.